5 results
To evaluate the safety and clinical performance of the LCP system in patients who are indicated for VVI(R) pacemaker.
To confirm previous study results using a Solace Balloon and to support future marketing efforts in the European Union and provide data for publications.
The purpose of this study is to explore the efficacy and safety of LTP001 in participants with WHO Group 1 pulmonary hypertension (PH), also referred to as Pulmonary Arterial Hypertension (PAH).This proof of concept study will be executed as theā¦
To assess the long term safety of LTP001 in participants with pulmonary arterial hypertension (PAH).
The purpose of the study is to look at how well the study treatment works in participants with idiopathic pulmonary fibrosis.